Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
第一作者:
Matthew J,Maurer
第一单位:
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA, 55902; Division of Hematology, Mayo Clinic, Rochester, MN, USA, 55905. maurer.matthew@mayo.edu.
作者:
医学主题词
人类(Humans);淋巴瘤, 滤泡性(Lymphoma, Follicular);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);老年人(Aged);成年人(Adult);抗体, 双特异性(Antibodies, Bispecific);治疗结果(Treatment Outcome);老年人, 80以上(Aged, 80 and over);抗药性, 肿瘤(Drug Resistance, Neoplasm);复发(Recurrence)
DOI
10.3324/haematol.2023.283737
PMID
38031804
发布时间
2025-01-04
- 浏览0
Haematologica
2177-2185页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



